Abstract
Nine strains of organisms morphologically and physiologically identified as Gaffkya tetragena were obtained from various sources to study their pathogenicity. Initial virulence analysis of all strains by mouse intraperitoneal injection of viable cells revealed that only three strains, recently isolated from and associated with respiratory infections in hospitalized patients, caused death of mice within 48 hr. The ld50 for these virulent, encapsulated strains was 1 × 107 to 6 × 107 viable organisms. To associate virulence with a toxic component, the following fractions were purified from all strains: capsular material, cell walls, mucopeptide preparations from cell walls and whole cells, grouplike material, cytoplasmic material, and culture filtrate with and without added reducing agent. Rabbit and mouse dermal toxicity testing of these fractions revealed that the capsular material, cell walls, and mucopeptide preparations of the virulent strains were toxic. None of the nonvirulent strains contained toxic components, with the exception of one strain which yielded capsular material equal in toxicity to that of the virulent strains. The capsular material induced a soft pustular lesion persisting for approximately 22 days. Cell walls and mucopeptide preparations produced a hard nodular lesion, identical to that produced by autoclaved whole cells, that persisted for 25 to 30 days. One strain may represent a virulence intermediate between the virulent and nonvirulent strains, since it contains toxic capsular material but nontoxic cell wall mucopeptide. The results indicate that the virulence of this organism is associated with toxic capsular material and cell wall mucopeptide.
Full text
PDF






Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abdulla E. M., Schwab J. H. Biological properties of streptococcal cell-wall particles. 3. Dermonecrotic reaction to cell-wall mucopeptides. J Bacteriol. 1966 Jan;91(1):374–383. doi: 10.1128/jb.91.1.374-383.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BRISOU J., MORICHAU-BEAUCHANT J., GIMENEZ J., LENRIOT A. Flore bactérienne des infections urinaires. Bull Soc Pathol Exot Filiales. 1952;45(4):439–442. [PubMed] [Google Scholar]
- Bulmer G. S., Sans M. D. Cryptococcus neoformans. 3. Inhibition of phagocytosis. J Bacteriol. 1968 Jan;95(1):5–8. doi: 10.1128/jb.95.1.5-8.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DUGUID J. P. The demonstration of bacterial capsules and slime. J Pathol Bacteriol. 1951 Oct;63(4):673–685. doi: 10.1002/path.1700630413. [DOI] [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- MOCK F. S., WYNNE E. S. The sensitivity of Gaffkya tetragena strains to penicillin and streptomycin. J Infect Dis. 1950 Jul-Aug;87(1):10–12. [PubMed] [Google Scholar]
- Maneval W. E. RAPID STAINING METHODS. Science. 1934 Sep 28;80(2074):292–294. doi: 10.1126/science.80.2074.292. [DOI] [PubMed] [Google Scholar]
- PARK J. T., HANCOCK R. A fractionation procedure for studies of the synthesis of cell-wall mucopeptide and of other polymers in cells of Staphylococcus aureus. J Gen Microbiol. 1960 Feb;22:249–258. doi: 10.1099/00221287-22-1-249. [DOI] [PubMed] [Google Scholar]
- ROBERSON B. S., SCHWAB J. H., CROMARTIE W. J. Relation of particle size of C polysaccharide complexes of group A streptococci to toxic effects on connective tissue. J Exp Med. 1960 Nov 1;112:751–764. doi: 10.1084/jem.112.5.751. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reimann H. A. MICROCOCCUS TETRAGENUS INFECTION: I. Review of the Literature, Report of a Non-fatal Case with Septicemia, Meningitis and Arthritis, and Bacteriologic Studies. J Clin Invest. 1935 May;14(3):311–319. doi: 10.1172/JCI100679. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reimann H. A. Micrococcus tetragenus Infection: II. Description of Variant Forms. J Bacteriol. 1936 Apr;31(4):385–405. doi: 10.1128/jb.31.4.385-405.1936. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SCHWAB J. H., CROMARTIE W. J., ROBERSON B. S. Identification of a toxic cellular component of group A streptococci as a complex of group-specific C polysaccharide and a protein. J Exp Med. 1959 Jan 1;109(1):43–54. doi: 10.1084/jem.109.1.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SCHWAB J. H., CROMARTIE W. J. Studies on a toxic cellular component of group A streptococci. J Bacteriol. 1957 Nov;74(5):673–679. doi: 10.1128/jb.74.5.673-679.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SPENCER A., VERA M., COZZI V., VIGOUROUX J. Endocarditis lenta bimicrobiana. Rev Med Chil. 1952 Jun;80(6):363–366. [PubMed] [Google Scholar]
- Schuster G. S., Hayashi J. A., Bahn A. N. Toxic properties of the cell wall of gram-positive bacteria. J Bacteriol. 1967 Jan;93(1):47–52. doi: 10.1128/jb.93.1.47-52.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schwab J. H., Ohanian S. H. Degradation of streptococcal cell wall antigens in vivo. J Bacteriol. 1967 Nov;94(5):1346–1352. doi: 10.1128/jb.94.5.1346-1352.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WYNNE E. S., NORMAN J. O. On the concept of direct antagonism in bacteria. J Infect Dis. 1953 Nov-Dec;93(3):243–246. doi: 10.1093/infdis/93.3.243. [DOI] [PubMed] [Google Scholar]
- ZELIGMAN I., SINESI S. J. Carbuncle caused by Gaffkya tetragena treated with oxytetracycline (terramycin). AMA Arch Derm Syphilol. 1953 Oct;68(4):382–384. doi: 10.1001/archderm.1953.01540100022003. [DOI] [PubMed] [Google Scholar]

